{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:55:57Z","timestamp":1772204157712,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,14]]},"DOI":"10.7759\/cureus.69422","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T22:01:36Z","timestamp":1726351296000},"source":"Crossref","is-referenced-by-count":1,"title":["Primary Retrovesical Leiomyosarcoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Raquel","family":"Rudy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I","family":"LeRoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel RL","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023, 73:17-48. 10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0035","article-title":"Soft tissue sarcoma, version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"von Mehren M","year":"2022","unstructured":"von Mehren M, Kane JM, Agulnik M, et al.. Soft tissue sarcoma, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022, 20:815-33. 10.6004\/jnccn.2022.0035","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives","volume":"113","author":"Sbaraglia M","year":"2021","unstructured":"Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica. 2021, 113:70-84. 10.32074\/1591-951X-213","journal-title":"Pathologica"},{"key":"ref4","unstructured":"National Cancer Institute. Seer Cancer Statistics Review, 1975-2010. (2024). Accessed: March 25, 2024: http:\/\/seer.cancer.gov\/csr\/ 1975_2010\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.9845","article-title":"Soft tissue and uterine leiomyosarcoma","volume":"36","author":"George S","year":"2018","unstructured":"George S, Serrano C, Hensley ML, Ray-Coquard I. Soft tissue and uterine leiomyosarcoma. J Clin Oncol. 2018, 36:144-50. 10.1200\/JCO.2017.75.9845","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-241466","article-title":"Challenging retrovesical mass in men: report of a rare liposarcoma case with concurrent COVID-19 infection","volume":"14","author":"Jamtani I","year":"2021","unstructured":"Jamtani I, Nugroho A, Rahadiani N, Manangka RS. Challenging retrovesical mass in men: report of a rare liposarcoma case with concurrent COVID-19 infection. BMJ Case Rep. 2021, 14:241466. 10.1136\/bcr-2020-241466","journal-title":"BMJ Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/686902","article-title":"Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre: reassessment in the era of ancillary molecular diagnosis","volume":"2014","author":"Thway K","year":"2014","unstructured":"Thway K, Wang J, Mubako T, Fisher C. Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre: reassessment in the era of ancillary molecular diagnosis. Sarcoma. 2014, 2014:686902. 10.1155\/2014\/686902","journal-title":"Sarcoma"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdr610","article-title":"Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions","volume":"23","author":"Ray-Coquard I","year":"2012","unstructured":"Ray-Coquard I, Montesco MC, Coindre JM, et al.. Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol. 2012, 23:2442-9.","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21605","article-title":"Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine","volume":"70","author":"Gamboa AC","year":"2020","unstructured":"Gamboa AC, Gronchi A, Cardona K. Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine. CA Cancer J Clin. 2020, 70:200-29. 10.3322\/caac.21605","journal-title":"CA Cancer J Clin"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1016\/j.soc.2022.03.011","article-title":"Leiomyosarcoma: Current clinical management and future horizons","volume":"31","author":"Devaud N","year":"2022","unstructured":"Devaud N, Vornicova O, Abdul Razak AR, et al.. Leiomyosarcoma: Current clinical management and future horizons. Surg Oncol Clin N Am. 2022, 31:527-46.","journal-title":"Surg Oncol Clin N Am"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31699","article-title":"Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma","volume":"124","author":"Keung EZ","year":"2018","unstructured":"Keung EZ, Chiang YJ, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer. 2018, 124:4495-503. 10.1002\/cncr.31699","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199809000-00008","article-title":"Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution","volume":"228","author":"Lewis JJ","year":"1998","unstructured":"Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998, 228:355-65. 10.1097\/00000658-199809000-00008","journal-title":"Ann Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf WT","year":"2012","unstructured":"van der Graaf WT, Blay JY, Chawla SP, et al.. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2012, 379:1879-86. 10.1016\/S0140-6736(12)60651-5","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276241-primary-retrovesical-leiomyosarcoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T22:01:41Z","timestamp":1726351301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276241-primary-retrovesical-leiomyosarcoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,14]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.69422","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,14]]}}}